Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Boosted by Microsoft's offerings, CVS intends to accelerate ... Expanding digital means CVS plans to improve its omnichannel pharmacy capabilities using Microsoft tools to provide personalised ...

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs ...

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

UnitedHealth's troubles were impacting its peers, as shares of CVS Health Corp. (CVS) slid 5.4%, Humana Inc.'s stock (HUM) shed 7.4%, Centene Corp. shares (CNC) dropped 4.8% and Elevance Health Inc.'s ...

Omada Health, a virtual chronic care provider, filed to go public Friday, marking the second digital health company making ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

UnitedHealth Group announced the immediate resignation of CEO Andrew Witty for personal reasons on Tuesday and withdrew its already-slashed full-year earnings outlook, citing a continued acceleration ...

Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.